Laddar...
Alemtuzumab for multiple sclerosis
BACKGROUND: Multiple sclerosis (MS) is an autoimmune, T‐cell‐dependent, inflammatory, demyelinating disease of the central nervous system, with an unpredictable course. Current MS therapies focus on treating exacerbations, preventing new exacerbations and avoiding the progression of disability. Howe...
Sparad:
| I publikationen: | Cochrane Database Syst Rev |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
John Wiley & Sons, Ltd
2016
|
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6486037/ https://ncbi.nlm.nih.gov/pubmed/27082500 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD011203.pub2 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|